Abstract
Food supplements have proven their effectiveness through the support offered to administer certain drugs and their ability to determine the prevention of degenerative diseases. The correlation of assay methods with individual-level observations is essential in understanding the effect of biopharmaceuticals as a useful tool for long-term homeostasis preservation. This paper aimed to present essential aspects related to using wild edible mushrooms as functional supplements in type 2 diabetes and associated cardiovascular diseases. The product RoBioMush was presented as a result of the scientific data applied within the university, and the effects recorded after the administration of the product to the target groups were highlighted. Thus, the administration of RoBioMush had as its main effect the regulation of intestinal transit, a fact demonstrated by the researched modulation process previously in an in vitro study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
